Starboard, which owns 7% of eHealth, said in a regulatory filing
that it feels the company's stock is undervalued, sending the
stock price up nearly 5% in after-hours trading.
Starboard nominated Peter Feld, a partner and the firm's
research director, plus three others.
EHealth said it has held discussions with Starboard and is "open
minded."
"The Board is reviewing Starboard’s nominees and will present
its formal recommendation in due course," the company said in a
statement.
The move comes less than two weeks after eHealth agreed with
hedge fund Hudson Executive Capital to add two independent
directors to the board, a move that already pushed the share
price higher.
The two sides agreed to add John Hass, the former CEO of Rosetta
Stone, immediately, bringing their board membership to eight,
and pledged to find another director in the coming weeks.
Hudson Executive, which owns roughly 5.8% of eHealth, had also
expressed concerns about the company's stock price.
The stock closed at $68.09 on Monday.
Starboard did not say what it would like to see at eHealth but
at other companies the firm has often pushed for sales of the
company or changes in top management.
As the pace of activism picks up this year after a more subdued
2020, companies can sometimes find themselves targeted by more
than one activist investor, bankers have said.
Starboard in particular is known to swoop in on a company that
has already battled with a different activist, suggesting it
considers itself better able to deliver on proposed changes than
other activists can.
It nominated directors at Elanco Animal Health in early March
after the company settled for three board seats with Sachem Head
Capital last year. Last year Starboard nominated directors at
eBay and Commvault, which had each settled with another activist
earlier.
(Reporting by Svea Herbst-Bayliss; Editing by Sonya Hepinstall)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|